GlassScriptPhysician profile
Douglas Peter Ead
NPI 1629537410
$288.10
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $14.99 · 2022: $118 · 2023: $16.67 · 2024: $138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $155.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $155.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $65.12 | 2022 | |
| Integra Lifesciences Corporation | $44.94 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Boston Scientific Corporation | $40.16 | 2024 | Wavewriter Alpha Prime 16 |
| Avanos Medical | $37.25 | 2024 | Coolief* Cooled Radiofrequency |
| Triad Life Sciences INC. | $18.33 | 2022 | |
| Curonix LLC | $17.87 | 2022 | |
| Smith+Nephew, INC. | $16.72 | 2022 | |
| Ferring Pharmaceuticals INC. | $16.67 | 2023 | Euflexxa |
| Solventum Corporation | $16.05 | 2024 | Prevena |
| Paratek Pharmaceuticals, INC. | $14.99 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Ead listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.